219 related articles for article (PubMed ID: 10726227)
1. Mechanisms of action of low doses of polyethylene glycol in the treatment of functional constipation.
Chaussade S
Ital J Gastroenterol Hepatol; 1999 Nov; 31 Suppl 3():S242-4. PubMed ID: 10726227
[TBL] [Abstract][Full Text] [Related]
2. Use of low dose polyethylene glycol solutions in the treatment of functional constipation.
Badiali D; Corazziari E
Ital J Gastroenterol Hepatol; 1999 Nov; 31 Suppl 3():S245-8. PubMed ID: 10726228
[TBL] [Abstract][Full Text] [Related]
3. Use of polyethylene glycol solution in slow transit constipation.
Bassotti G; Fiorella S; Roselli P; Modesto R
Ital J Gastroenterol Hepatol; 1999 Nov; 31 Suppl 3():S255-6. PubMed ID: 10726231
[TBL] [Abstract][Full Text] [Related]
4. Use of polyethylene glycol solution in functional and organic constipation in children.
Staiano A
Ital J Gastroenterol Hepatol; 1999 Nov; 31 Suppl 3():S260-3. PubMed ID: 10726233
[TBL] [Abstract][Full Text] [Related]
5. Polyethylene glycol 4000 for slow transit constipation.
Klauser AG; Mühldorfer BE; Voderholzer WA; Wenzel G; Müller-Lissner SA
Z Gastroenterol; 1995 Jan; 33(1):5-8. PubMed ID: 7886986
[TBL] [Abstract][Full Text] [Related]
6. Polyethylene glycol 4000 vs. lactulose for the treatment of neurogenic constipation in myelomeningocele children: a randomized-controlled clinical trial.
Rendeli C; Ausili E; Tabacco F; Focarelli B; Pantanella A; Di Rocco C; Genovese O; Fundarò C
Aliment Pharmacol Ther; 2006 Apr; 23(8):1259-65. PubMed ID: 16611288
[TBL] [Abstract][Full Text] [Related]
7. Need of the ideal drug for the treatment of chronic constipation.
Corazziari E
Ital J Gastroenterol Hepatol; 1999 Nov; 31 Suppl 3():S232-3. PubMed ID: 10726224
[TBL] [Abstract][Full Text] [Related]
8. New polyethylene glycol electrolyte solution for the treatment of constipation and faecal impaction.
Ferguson A; Culbert P; Gillett H; Barras N
Ital J Gastroenterol Hepatol; 1999 Nov; 31 Suppl 3():S249-52. PubMed ID: 10726229
[TBL] [Abstract][Full Text] [Related]
9. Polyethylene glycol solution in subgroups of chronic constipation patients: experience in obstructed defaecation.
Bazzocchi G
Ital J Gastroenterol Hepatol; 1999 Nov; 31 Suppl 3():S257-9. PubMed ID: 10726232
[TBL] [Abstract][Full Text] [Related]
10. Effects of lactulose and polyethylene glycol on colonic transit.
Fritz E; Hammer HF; Lipp RW; Högenauer C; Stauber R; Hammer J
Aliment Pharmacol Ther; 2005 Feb; 21(3):259-68. PubMed ID: 15691300
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and optimal dose of daily polyethylene glycol 3350 for treatment of constipation and encopresis in children.
Pashankar DS; Bishop WP
J Pediatr; 2001 Sep; 139(3):428-32. PubMed ID: 11562624
[TBL] [Abstract][Full Text] [Related]
12. A randomized, placebo-controlled, multicenter study of the safety and efficacy of a new polyethylene glycol laxative.
DiPalma JA; DeRidder PH; Orlando RC; Kolts BE; Cleveland MB
Am J Gastroenterol; 2000 Feb; 95(2):446-50. PubMed ID: 10685748
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of polyethylene glycol plus electrolytes in the treatment of severe constipation and faecal impaction in adults.
Chen CC; Su MY; Tung SY; Chang FY; Wong JM; Geraint M
Curr Med Res Opin; 2005 Oct; 21(10):1595-602. PubMed ID: 16238899
[TBL] [Abstract][Full Text] [Related]
14. Clinical subgroups of chronic constipation: exploring the potential of polyethylene glycol.
Camilleri M
Ital J Gastroenterol Hepatol; 1999 Nov; 31 Suppl 3():S253-4. PubMed ID: 10726230
[TBL] [Abstract][Full Text] [Related]
15. A randomized, prospective, comparison study of polyethylene glycol 3350 without electrolytes and milk of magnesia for children with constipation and fecal incontinence.
Loening-Baucke V; Pashankar DS
Pediatrics; 2006 Aug; 118(2):528-35. PubMed ID: 16882804
[TBL] [Abstract][Full Text] [Related]
16. Small doses of the unabsorbable substance polyethylene glycol 3350 accelerate oro-caecal transit, but slow gastric emptying in healthy subjects.
Coremans G; Vos R; Margaritis V; Ghoos Y; Janssens J
Dig Liver Dis; 2005 Feb; 37(2):97-101. PubMed ID: 15733521
[TBL] [Abstract][Full Text] [Related]
17. An open-label study of chronic polyethylene glycol laxative use in chronic constipation.
Di Palma JA; Cleveland MV; McGowan J; Herrera JL
Aliment Pharmacol Ther; 2007 Mar; 25(6):703-8. PubMed ID: 17311603
[TBL] [Abstract][Full Text] [Related]
18. Effect of 5 days linaclotide on transit and bowel function in females with constipation-predominant irritable bowel syndrome.
Andresen V; Camilleri M; Busciglio IA; Grudell A; Burton D; McKinzie S; Foxx-Orenstein A; Kurtz CB; Sharma V; Johnston JM; Currie MG; Zinsmeister AR
Gastroenterology; 2007 Sep; 133(3):761-8. PubMed ID: 17854590
[TBL] [Abstract][Full Text] [Related]
19. Prospective, randomized, parallel-group trial to evaluate the effects of lactulose and polyethylene glycol-4000 on colonic flora in chronic idiopathic constipation.
Bouhnik Y; Neut C; Raskine L; Michel C; Riottot M; Andrieux C; Guillemot F; Dyard F; Flourié B
Aliment Pharmacol Ther; 2004 Apr; 19(8):889-99. PubMed ID: 15080850
[TBL] [Abstract][Full Text] [Related]
20. A dose determination study of polyethylene glycol 4000 in constipated children: factors influencing the maintenance dose.
Dupont C; Leluyer B; Amar F; Kalach N; Benhamou PH; Mouterde O; Vannerom PY
J Pediatr Gastroenterol Nutr; 2006 Feb; 42(2):178-85. PubMed ID: 16456412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
